Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?-Reference-Cited by-同舟云学术

Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?

Published:2017-09-27 Issue:15 Volume:18 Page:1583-1594
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Inchingolo Riccardo¹^ORCID,Condoluci Carola¹,Smargiassi Andrea¹,Mastrobattista Annelisa¹,Boccabella Cristina¹,Comes Alessia¹,Golfi Nicoletta¹,Richeldi Luca¹

Affiliation:

1. Unità Operativa Complessa di Pneumologia, Università Cattolica del Sacro Cuore, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1383382

Reference104 articles.

1. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

2. Idiopathic pulmonary fibrosis

3. Tissue remodelling in pulmonary fibrosis

4. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

5. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF);Journal of Medicinal Chemistry;2020-09-24

2. Protective effects of isorhynchophylline against silicon-dioxide-induced lung injury in mice;Artificial Cells, Nanomedicine, and Biotechnology;2020-01-01

3. Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice;Biomedicine & Pharmacotherapy;2019-07

4. Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis;Current Pulmonology Reports;2018-10-29

5. Nintedanib for the treatment of idiopathic pulmonary fibrosis;Expert Opinion on Pharmacotherapy;2018-01-12